Former GlaxoSmithKline Plc executive Moncef Slaoui, who is set to become the chief scientist for Operation Ward Speed, the White House effort to turbocharge vaccine development, has been a board member at Moderna since 2017. According to a person familiar with the matter, he will leave that and other board seats once he starts the position.